Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Departments

Value of Self-Monitoring of Blood Glucose in Non-Insulin-Using Patients With Type 2 Diabetes

  1. Michael Pignone, MD, MPH
    Clinical Diabetes 2009 Dec; 27(1): 17-18. https://doi.org/10.2337/diaclin.27.1.17
    PreviousNext
    • Article
    • Info & Metrics
    • PDF
    Loading

    STUDY

    O'Kane MJ, Bunting B, Copeland M, Coates VE; ESMON Study Group: Efficacy of self-monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 336:1174-1177, 2008

    SUMMARY

    Design. A randomized controlled trial.

    Subjects. Participants included 184 adults with newly diagnosed type 2 diabetes who were not taking insulin.

    Methods. Participants were randomized to receive either a structured educational program alone or a structured educational program plus additional training and advice about self-monitoring of blood glucose (SMBG). All participants received follow-up visits every 3 months with predefined treatment algorithms based on A1C level. Patients in the SMBG group were asked to complete four fasting and four postprandial measures per week and were given advice about what to do in response to high SMBG readings.

    Results. Adherence to SMBG was good: 66% of participants in the SMBG group completed > 80% of requested measures. No differences between groups were observed in A1C at 12 months (6.9% in each group; mean difference 0.07%; 95% confidence interval -0.25 to 0.38) or in the incidence of hypoglycemia. Those in the SMBG group had somewhat higher scores on the depression subscale of a well-being questionnaire.

    Conclusions. The addition of SMBG did not appear to provide additional benefit for newly diagnosed, non-insulin-using patients with type 2 diabetes who were receiving care in an organized program with a strong educational component.

    COMMENTARY

    The question of whether to recommend regular SMBG among patients with type 2 diabetes who are not taking insulin remains widely debated within the medical community.1 The potential benefits of SMBG include providing motivation and feedback for patients about medication changes, dietary programs, or exercise regimens, including resultant improvements in self-efficacy, as well as the ability to detect and treat hypo- or hyperglycemia. Potential downsides include the possibility of increasing negative emotions, the discomfort related to obtaining samples, and the opportunity costs of the substantial patient time and resources devoted to monitoring.2 The costs to health care systems are also substantial; Davidson estimated the cost to Medicare for SMBG in 2002 to be > $465 million.3

    Several previous trials have attempted to determine the benefits of SMBG. A systematic review and meta-analysis in 2005 identified six trials and suggested that SMBG was associated with an improvement of 0.39 percentage points in A1C. The reviewers noted that differences in co-interventions (amount and type of education) may have affected the results. Subsequently, another trial found no difference with SMBG in a group of non-insulin-treated patients with relatively good glycemic control (mean A1C 7.5%) at baseline.4

    The ESMON trial overcomes some of the methodological limitations of previous studies. Most importantly, the educational intervention and care algorithms were the same for both groups, allowing an evaluation of the specific impact of education, training, and performance of SMBG. Initial A1C levels were high enough (8.8 and 8.6%) to allow room for improvement. Outcomes included both potential benefits (A1C and hypoglycemia) and potential harms (well-being). Costs, including patient time, were not reported. The findings of little or no benefit with SMBG, coupled with possible reductions in well-being, suggest that routine use of SMBG is not beneficial for non-insulin users within the context of a well-organized program of diabetes care that includes frequent assessments of A1C followed by algorithm-based medication adjustment.

    Footnotes

    • Michael Pignone, MD, MPH, is an associate professor of medicine at the University of North Carolina Department of Medicine in Chapel Hill and an associate editor of Clinical Diabetes.

    • American Diabetes Association(R) Inc., 2009

    REFERENCES

    1. ↵
      1. Welschen LM,
      2. Bloemendal E,
      3. Nijpels G,
      4. Dekker JM,
      5. Heine RJ,
      6. Stalman WA,
      7. Bouter LM
      : Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28:1510-1517, 2005
      OpenUrlAbstract/FREE Full Text
    2. ↵
      1. Russell LB,
      2. Suh DC,
      3. Safford MA
      : Time requirements for diabetes self-management: too much for many? J Fam Pract 54:52-56, 2005
      OpenUrlFREE Full Text
    3. ↵
      1. Davidson M
      : Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin. Diabetes Care 28:1531-1533, 2005
      OpenUrlPubMedWeb of Science
    4. ↵
      1. Farmer A,
      2. Wade A,
      3. Goyder E,
      4. Yudkin P,
      5. French D,
      6. Craven A,
      7. Holman R,
      8. Kinmonth AL,
      9. Neil A
      : Impact of self-monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 335:132, 2007
      OpenUrlFREE Full Text
    PreviousNext
    Back to top

    In this Issue

    December 2009, 27(1)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Clinical Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Value of Self-Monitoring of Blood Glucose in Non-Insulin-Using Patients With Type 2 Diabetes
    (Your Name) has forwarded a page to you from Clinical Diabetes
    (Your Name) thought you would like to see this page from the Clinical Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Value of Self-Monitoring of Blood Glucose in Non-Insulin-Using Patients With Type 2 Diabetes
    Michael Pignone
    Clinical Diabetes Dec 2009, 27 (1) 17-18; DOI: 10.2337/diaclin.27.1.17

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Value of Self-Monitoring of Blood Glucose in Non-Insulin-Using Patients With Type 2 Diabetes
    Michael Pignone
    Clinical Diabetes Dec 2009, 27 (1) 17-18; DOI: 10.2337/diaclin.27.1.17
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • STUDY
      • SUMMARY
      • COMMENTARY
      • Footnotes
      • REFERENCES
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    Departments

    • Glycemic Control During Gender-Affirming Therapy in a Patient With Type 1 Diabetes
    • Good to Know: Nerve Damage and Diabetes
    • Community Primary Care Diabetes Pathway
    Show more Departments

    Landmark Studies

    • Television Viewing Increases Risk of Type 2 Diabetes, Cardiovascular Disease, and Mortality
    • The Effect of Fruit and Vegetable Intake on the Incidence of Diabetes
    • High-Protein and Low-Glycemic Diets Improve Weight Maintenance Among Overweight Adults
    Show more Landmark Studies

    Similar Articles

    Navigate

    • Current Issue
    • Papers in Press
    • Abridged Standards of Care
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.